BriLife

2021-07-27 22:17:10

BriLife, also known as IIBR-100, is a vector-based COVID-19 vaccine candidate developed by the Israel Institute for Biological Research.

BriLife, also known as IIBR-100, is a vector-based COVID-19 vaccine candidate developed by the Israel Institute for Biological Research.
Read article on Wikipedia